Stay updated on PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T23:18:16.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The website has updated the intervention details to include a verified status by Ms. Jann Lee and has moved to revision v2.14.0, while the previous type of intervention has been removed.
    Difference
    0.9%
    Check dated 2025-01-12T18:18:20.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    No Change Detected
  6. Check
    37 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T22:41:27.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.
    Difference
    3%
    Check dated 2024-12-07T16:09:34.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    Several links related to rare diseases and clinical trials have been removed, including those for glioblastoma and glioma, as well as resources from NIH and Dailymed.
    Difference
    4%
    Check dated 2024-11-23T04:33:06.000Z thumbnail image
  9. Check
    65 days ago
    Change Detected
    Summary
    New resources related to rare diseases and treatment options, including specific links for glioblastoma, gliosarcoma, glioma, and neuroepithelioma, have been added, along with links to major health and government websites.
    Difference
    0.5%
    Check dated 2024-11-15T23:35:22.000Z thumbnail image

Stay in the know with updates to PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page.